Chlorphenesin carbamate
Star1
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Chlorphenesin carbamate
- DrugBank Accession Number
- DB14656
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Vet approved, Withdrawn
- Structure
- Weight
- Average: 245.66
Monoisotopic: 245.0454856 - Chemical Formula
- C10H12ClNO4
- Synonyms
- 1,2-propanediol-3-(p-chlorophenoxy)-1-carbamate
- 3-(4-chlorophenoxy)-1,2-propanediol-1-carbamate
- 3-(p-chlorophenoxy)-1,2-propanediol 1-carbamate
- 3-(p-chlorophenoxy)-2-hydroxypropyl carbamate
- carbamic acid 3-(p-chlorophenoxy)-2-hydroxypropyl ester
- Chlorphenesin carbamate
- External IDs
- U 19646
- U-19,646
- U-19646
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Kolpicortin / Maolate (UpJohn) / Rinlaxer
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Phenol ethers
- Sub Class
- Not Available
- Direct Parent
- Phenol ethers
- Alternative Parents
- Phenoxy compounds / Chlorobenzenes / Alkyl aryl ethers / Aryl chlorides / Carbamate esters / Secondary alcohols / Organic carbonic acids and derivatives / Organopnictogen compounds / Organonitrogen compounds / Organochlorides show 3 more
- Substituents
- Alcohol / Alkyl aryl ether / Aromatic homomonocyclic compound / Aryl chloride / Aryl halide / Carbamic acid ester / Carbonic acid derivative / Carbonyl group / Chlorobenzene / Ether show 14 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- carbamate ester, secondary alcohol, monochlorobenzenes (CHEBI:3643)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 57U5YI11WP
- CAS number
- 886-74-8
- InChI Key
- SKPLBLUECSEIFO-UHFFFAOYSA-N
- InChI
- InChI=1S/C10H12ClNO4/c11-7-1-3-9(4-2-7)15-5-8(13)6-16-10(12)14/h1-4,8,13H,5-6H2,(H2,12,14)
- IUPAC Name
- 3-(4-chlorophenoxy)-2-hydroxypropyl carbamate
- SMILES
- NC(=O)OCC(O)COC1=CC=C(Cl)C=C1
References
- General References
- Not Available
- External Links
- KEGG Drug
- D00770
- KEGG Compound
- C07930
- ChemSpider
- 2623
- ChEBI
- 3643
- ChEMBL
- CHEMBL607710
- Wikipedia
- Chlorphenesin_carbamate
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 1 Active Not Recruiting Treatment Pancreatic Cancer 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 1.39 mg/mL ALOGPS logP 0.96 ALOGPS logP 1.21 Chemaxon logS -2.2 ALOGPS pKa (Strongest Acidic) 13.61 Chemaxon pKa (Strongest Basic) -3.4 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 81.78 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 57.41 m3·mol-1 Chemaxon Polarizability 23.8 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0f92-8790000000-b714eb357b4beb6a9d12 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-000f-9000000000-085d65052ec5d6b02df3 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-006x-9200000000-67e1dbcb86d887e40c5b Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0v09-5900000000-24e27ab3ef03b133ac71 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-002f-9500000000-61b035b0ebd1b5c9e5a1 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0006-6910000000-5cfe7a934afa05fff26c Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 148.73369 predictedDeepCCS 1.0 (2019) [M+H]+ 151.09169 predictedDeepCCS 1.0 (2019) [M+Na]+ 157.48988 predictedDeepCCS 1.0 (2019)
Drug created at September 02, 2018 00:15 / Updated at February 21, 2021 18:54